{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:11:21Z","timestamp":1780549881580,"version":"3.54.1"},"reference-count":51,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuromuscular Diseases"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To investigate how parents of children with SMA who are treated with disease modifying therapies cope with hopes and worries related to disease progression, and to investigate their needs for counseling and rehabilitation initiatives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The design of this study was qualitative using the Interpretive Description methodology and Joyce Travelbee's theory of interpersonal aspects. The method was semi-structured interviews conducted in Denmark at the homes of the parents or through the online platform Teams between February 29 and May 3, 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings:<\/jats:title>\n                    <jats:p>Seventy-five parents representing 41 children were invited. Twenty-six parents of 20 children participated in the study. Twenty-four parents were interviewed at home and two were interviewed online. The key element of the parents\u2019 narratives was the reality of the diagnosis: the trajectory toward the diagnosis, getting the diagnosis, and the hope related to the effect af disease modifying therapies. At the same time, they experienced grief related to the uncertainty of the disease progression while hoping for normalcy in the future: a \u2018normal\u2019 child and a \u2018normal\u2019 life. Finally, they struggled with balancing professional counseling to maintain hope.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The families need coordinated, multidisciplinary care and information on disease modifying therapies, including what they can actively do to increase the effectiveness of the treatment. Counseling should include facilitated peer-support and acknowledge differences in children in terms of development, how they respond to the disease modifying therapy, and its long-term effects. Health professionals must tailor their support to the families\u2019 needs and sustain their hopes for the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/22143602251392800","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:05:40Z","timestamp":1761843940000},"page":"373-387","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Disease modifying therapies for children with spinal muscular atrophy - parents\u2019 experiences of hopes, grief and need for rehabilitation for their child"],"prefix":"10.1177","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1378-2449","authenticated-orcid":false,"given":"Charlotte","family":"Handberg","sequence":"first","affiliation":[{"name":"National Rehabilitation Center for Neuromuscular Diseases"},{"name":"Department of Public Health, Faculty of Health, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5109-9147","authenticated-orcid":false,"given":"Pia Zinck","family":"Drivsholm","sequence":"additional","affiliation":[{"name":"National Rehabilitation Center for Neuromuscular Diseases"},{"name":"Department of Public Health, Faculty of Health, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5294-2046","authenticated-orcid":false,"given":"Ulla","family":"Werlauff","sequence":"additional","affiliation":[{"name":"National Rehabilitation Center for Neuromuscular Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7194-6831","authenticated-orcid":false,"given":"Sanne Okkels Birk","family":"Lorenzen","sequence":"additional","affiliation":[{"name":"National Rehabilitation Center for Neuromuscular Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8567-9686","authenticated-orcid":false,"given":"Annette","family":"Mahoney","sequence":"additional","affiliation":[{"name":"National Rehabilitation Center for Neuromuscular Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-022-00380-8"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000001403"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200310"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.3233\/JND-221672"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2015.07.004"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-023-04883-8"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2022.2056836"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-00413-4"},{"key":"e_1_3_4_10_2","unstructured":"U.S. Food and Drug Administration. FDA https:\/\/www.fda.gov\/ (2025)."},{"key":"e_1_3_4_11_2","unstructured":"European Medicines Agency. Science Medicines Health. EMA https:\/\/www.ema.europa.eu\/en\/homepage (2025)."},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00437"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200224"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0044-1791201"},{"key":"e_1_3_4_15_2","unstructured":"Medicinr\u00e5det. Spinal Muscular Atrophy - Treatment guidelines and drug recommendations [Spinal Muskelatrofi - Behandlingsvejledning og l\u00e6gemiddelrekommandationer] https:\/\/medicinraadet.dk\/om-os\/medicinradets-arbejde\/behandlingsvejledninger-og-laegemiddelrekommandationer (2023)."},{"key":"e_1_3_4_16_2","unstructured":"The Ministry of the Interior and Health. Newborns should be screened for muscular dystrophy [Nyf\u00f8dte skal screenes for muskelsvind https:\/\/sum.dk\/nyheder\/2022\/oktober\/nyfoedte-skal-screenes-for-muskelsvind (2022)."},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1702752"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/17482631.2021.1904722"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1520467"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2006.01666.x"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02525-0"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.4324\/9781315426259"},{"key":"e_1_3_4_23_2","volume-title":"Interpretive description - an applied research methodology [Interpretive description - En anvendelsesorienteret forskningsmetodologi]","author":"Handberg C","year":"2021","unstructured":"Handberg C, Jensen AL. Interpretive description - an applied research methodology [Interpretive description - En anvendelsesorienteret forskningsmetodologi]. 1st ed. 2021, ISBN 9788772194400. Aarhus: Aarhus University Press.","edition":"1"},{"key":"e_1_3_4_24_2","volume-title":"Interpersonal aspects of nursing","author":"Travelbee J","year":"1996","unstructured":"Travelbee J, Travelbee J, Travelbee J. Interpersonal aspects of nursing. Oslo: Pensumtjeneste, 1996, Norway."},{"key":"e_1_3_4_25_2","unstructured":"RCFM National Rehabilitation Center for Neuromsucular Diseases [RehabiliteringsCenter for Muskelsvind]. Website for the National Rehabilitation Center for Neuromuscular Diseases - RCFM 2024 http:\/\/rcfm.dk\/ (2024)."},{"key":"e_1_3_4_26_2","unstructured":"Ministry of Interior and Health. The Danish Health Act [Sundhedsloven] https:\/\/www.retsinformation.dk\/eli\/lta\/2022\/210 (2018)."},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-08557-3"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.2217\/nmt-2022-0024"},{"key":"e_1_3_4_29_2","unstructured":"Canadian Institutes of Health R. Strategy for patient-oriented research. SPOR. Putting Patients First. Patient Engagement Framework. Canada: Canadian Institutes of Health Research; 2014. Contract No.: Report."},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-015-0473-3"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2014.147"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-020-00415-w"},{"key":"e_1_3_4_33_2","article-title":"Nusinersen treatment of spinal muscular atrophy - a systematic review","volume":"67","author":"Albrechtsen SS","year":"2020","unstructured":"Albrechtsen SS, Born AP, Boesen MS. Nusinersen treatment of spinal muscular atrophy - a systematic review. Dan Med J 2020; 67: 1\u201312.","journal-title":"Dan Med J"},{"key":"e_1_3_4_34_2","first-page":"1","article-title":"Current and emerging targeted therapies for spinal muscular atrophy","author":"Lakhina Y","year":"2023","unstructured":"Lakhina Y, Boulis NM, Donsante A. Current and emerging targeted therapies for spinal muscular atrophy. Expert Rev Neurother 2023, 12: 1\u201311.","journal-title":"Expert Rev Neurother"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914873"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.3233\/JND-190424"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01477-7"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1177\/0883073818822900"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.1062390"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/nin.12527"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12134183"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/ANS.0000000000000438"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13010-020-00087-2"},{"key":"e_1_3_4_44_2","volume-title":"What is a human being? [Hvad er et menneske?]","author":"Brinkmann S","year":"2019","unstructured":"Brinkmann S. What is a human being? [Hvad er et menneske?]. 1st ed. Copenhagen, Denmark: Gyldendal, 2019.","edition":"1"},{"key":"e_1_3_4_45_2","first-page":"1","article-title":"\u201cI was worried about not being good enough\u201d. Experiences and perspectives on pregnancy, childbirth and parenthood when living with a neuromuscular disorder - an exploration of everyday life challenges","author":"Handberg C","year":"2020","unstructured":"Handberg C, Myrup P, H\u00f8jberg AL. \u201cI was worried about not being good enough\u201d. Experiences and perspectives on pregnancy, childbirth and parenthood when living with a neuromuscular disorder - an exploration of everyday life challenges. Disabil Rehabil 2020; 44: 1\u20139.","journal-title":"Disabil Rehabil"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02407-5"},{"key":"e_1_3_4_47_2","unstructured":"SMA Europe. The 2025 Pan-European Survey on SMA and treatment through SMA medicines. EUPESMA Series https:\/\/www.sma-europe.eu\/eupesma-series (2025)."},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01701-y"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2017.10.008"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40359-024-02070-4"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-024-00758-0"},{"key":"e_1_3_4_52_2","unstructured":"The World Medical Association. WMA Declaration of Helsinki - ethical principles for medical research involving human subjects. In (Vol. 2016) https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/ (2016)."}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/22143602251392800","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/22143602251392800","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/22143602251392800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:57:53Z","timestamp":1780549073000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/22143602251392800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1177\/22143602251392800"],"URL":"https:\/\/doi.org\/10.1177\/22143602251392800","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]}}}